Mega-trials and management of acute myocardial infarction
- 1 September 1995
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 346 (8975), 611-614
- https://doi.org/10.1016/s0140-6736(95)91440-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarctionThe Lancet, 1995
- ACE Inhibition in Acute Myocardial InfarctionNew England Journal of Medicine, 1995
- Myocardial infarction: ACE inhibitors for all? for ever?The Lancet, 1994
- GISSI-3The Lancet, 1994
- Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)The Lancet, 1994
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials.BMJ, 1991
- Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location.Circulation, 1988
- EFFECT OF INTRAVENOUS NITRATES ON MORTALITY IN ACUTE MYOCARDIAL INFARCTION: AN OVERVIEW OF THE RANDOMISED TRIALSThe Lancet, 1988
- Why do we need some large, simple randomized trials?Statistics in Medicine, 1984